Testing effectiveness (Phase 2)UnknownNCT04848597What this trial is testingPD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUPWho this might be right forCancer of Unknown Primary Fudan University 48
Post-approval studies (Phase 4)UnknownNCT05291910What this trial is testingInetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast CancerWho this might be right forBreast Cancer Chinese Academy of Medical Sciences 70
Large-scale testing (Phase 3)Study completedNCT03099382What this trial is testingStudy of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal CancerWho this might be right forEsophageal Carcinoma Jiangsu HengRui Medicine Co., Ltd. 457
Testing effectiveness (Phase 2)Study completedNCT02648282What this trial is testingStudy With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Testing effectiveness (Phase 2)Looking for participantsNCT06981325What this trial is testingEvaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) PatientsWho this might be right forBasal Cell Carcinoma (BCC)First Line Treatment Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 34
Testing effectiveness (Phase 2)UnknownNCT04527068What this trial is testingQL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal CancerWho this might be right forRefractory Metastatic Colorectal CancerpMMRMSS Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Early research (Phase 1)Study completedNCT04223804What this trial is testingEvaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1Who this might be right forHuman Immunodeficiency Virus (HIV)HIV InfectionHIV-1 AbbVie 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT05661955What this trial is testingInvestigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.Who this might be right forUrothelial CarcinomaRenal Cell CarcinomaMelanoma+1 more BeiGene 113
Testing effectiveness (Phase 2)Study completedNCT03003468What this trial is testingPembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017Who this might be right forNon-Small Cell Lung Cancer Lawrence Feldman, MD 35
Large-scale testing (Phase 3)Not Yet RecruitingNCT06542549What this trial is testingEfficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian CancerWho this might be right forAdvanced Ovarian CancerAK104(PD-1/CTLA-4 Bispecial Antibody)Chemotherapy+2 more Anhui Provincial Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05781958What this trial is testingCadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICCWho this might be right forIntrahepatic Cholangiocarcinoma Shen Feng 64
Testing effectiveness (Phase 2)UnknownNCT04749485What this trial is testingHX008 for the Treatment of Patients With Malignant MelanomaWho this might be right forMelanoma Taizhou Hanzhong biomedical co. LTD 119
Large-scale testing (Phase 3)Active Not RecruitingNCT05152147What this trial is testingZanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersWho this might be right forGastric NeoplasmsGastroesophageal AdenocarcinomaEsophageal Adenocarcinoma Jazz Pharmaceuticals 920
Testing effectiveness (Phase 2)Active Not RecruitingNCT03930498What this trial is testingProgrammed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal CarcinomaWho this might be right forRecurrent Nasopharyngeal Carcinoma Sun Yat-sen University 68
Testing effectiveness (Phase 2)WithdrawnNCT03775707What this trial is testingLenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven CriteriaWho this might be right forHepatocellular Carcinoma Shi Ming
Testing effectiveness (Phase 2)Ended earlyNCT03430063What this trial is testingREGN2810 and Ipilimumab in Patients With Lung CancerWho this might be right forAdvanced Non-Small Cell Lung Carcinoma Regeneron Pharmaceuticals 28
Testing effectiveness (Phase 2)UnknownNCT04006821What this trial is testingPD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric AdenocarcinomaWho this might be right forGastric CancerAFP China Medical University, China 30
Testing effectiveness (Phase 2)Looking for participantsNCT04577014What this trial is testingRetifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue SarcomaWho this might be right forSoft Tissue SarcomaSarcoma,Soft TissueSarcoma+1 more Memorial Sloan Kettering Cancer Center 98
Early research (Phase 1)Looking for participantsNCT05645276What this trial is testingAK129 in Patients With Advanced Malignant TumorsWho this might be right forAdvanced Malignant Tumors(Stage IA-IB) Akeso 182
Early research (Phase 1)Study completedNCT04047862What this trial is testingStudy of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid TumorsWho this might be right forLocally Advanced and Metastatic Solid Tumors BeiGene 446